A stable B.C.G. vaccine, prepared and distributed in the freeze-dried form, is now accepted for use in many parts of the world. Recent trials (Medical Research Council, 1958 Griffiths and Gaisford, 1956 ) have confirmed that the freeze-dried vaccine induces a high degree of tuberculin sensitivity without untoward local reactions. From its stability the freeze-dried vaccine has undoubted advantages over a liquid vaccine, particularly because it permits standardization and safety-testing to be completed before issue. Nevertheless, since the vaccine contains living cells, of which an optimal number is essential for the efficacy of B.C.G. vaccination, great care has to be taken to ensure that the vaccine is not exposed to elevated temperatures even for relatively short periods. It is therefore obvious that a heatresistant freeze-dried B.C.G. vaccine that could be kept at temperatures up to 370 C. for a few weeks would have advantages, since it could then be distributed under unrefrigerated conditions and transported in tropical and subtropical countries without special precautions.
Numerous attempts have been made to improve the heat-stability of freeze-dried B.C.G. vaccine. Almost all of them have concentrated on the medium in which the organisms are freeze-dried, since this has usually been regarded as the most important factor affecting loss of viability during both freeze-drying and subsequent storage. Thus, for example, Miller and Goodner (1953) showed that sodium glutamate, as well as sodium aspartate and ascorbic acid, when included in the menstruum, increased the stability of the vaccine on storage. Cho and Obayashi (1956) , working with the Japanese strain of B.C.G., concluded that the inclusion of I % sodium glutamate provided one of the best media for freeze-drying B.C.G. Greaves (1960) , in studies with Bacterium paracoli and Nelsseria gonorrhoeae, also found that the presence of sodium glutamate in the drying medium gave subsequent enhanced stability at elevated temperatures. The rationale behind these improvements has been given by Scott (1960) . In work on Salmonella newport he showed that the sucrose included in the menstruum gave better stability during storage than did glucose or arabinose, both of which contain an available carbonyl group. He advanced the theory that the action of the menstruum is one of inhibiting or preventing damage to the micro-organisms resulting from the reaction between cellular protein and available carbonyl groups.
In our laboratory the actions of many different media for freeze-drying B.C.G. have been investigated: they have included that of sodium glutamate (Muggleton, 1960) . Under our conditions and with Sour substrain of B.C.G., however, no outstanding improvement in survival on storage at elevated temperatures was seen with any of these media, and none showed any great merit, such as had been claimed by the Japanese workers.
It was logical to assume that other factors could influence the stability of the dried vaccine, and it was decided to investigate the culture medium in which the B.C.G. was grown. In previous experimental work (Ungar et al., 1956) Dubos and Fenner (1950) , searching for a medium for the optimal growth of B.C.G., found that a striking decrease in viability of the culture occurred on prolonged incubation if 0.5 % glycerol had been added to the medium instead of glucose.
It was decided to produce a medium without glycerol for the growth of B.C.G. and to study the properties of a freeze-dried B.C.G. vaccine prepared from organisms grown therein. Experimental
Glycerol-free Medium
After numerous attempts to produce a medium without glycerol in which, with the addition of 1/4,000 w/v triton WR 1339, the B.C.G. strain would grow in deep culture, the formula given below was devised-the composition of the modified Sauton's medium used previously (Ungar et al., 1956) The pH value of each medium was adjusted to 7.4, and they were dispensed in l00-ml. amounts into mould culture (" penicillin ") flasks of about 2 litres capacity. The medium was sterilized in the autoclave at 15-lb. (6.8 kg.) pressure for 20 minutes.
Strain of B.C.G.
The Danish (" Copenhagen ") strain of B.C.G. was used in this work. The master cultures were maintained in the freeze-dried state, from which they were recovered on Lowenstein-Jensen medium as required. From these cultures they were transferred three times through Dubos's liquid medium to produce a "deep-growth" homogeneous inoculum. The third Dubos culture, after seven days' incubation at 370 C., was used as inoculum for the p-roduction cultures.
The production cultures were incubated at 37°C. for 12 days. Growth in either the Sauton's medium or the glycerol-free medium was similar, both taking place deep in the medium. The organisms tended to collect at the bottom of the culture, but a gentle swirl produced a uniform turbidity of unclumped cells. The cells were harvested by centrifuging in a refrigerated MSE " Major" centrifuge at approximately 3,000 g for 30 minutes.
Preparation of Freeze-dried Vaccine
Dried vaccine was made from the cells grown in the two types of medium by the method we have described previously (Ungar et al., 1956 ). The freeze-drying menstruum consisted of dextran 8.3%, glucose 7.5%, and triton WRI 339 0.025%. The primary freeze-drying and secondary drying (over P205) conditions were controlled so as to leave a final residual moisture of approximately 1% in the freeze-dried vaccine. The ampoules were sealed in vacuo (about 0.05 mm. Hg).
Viability Counts
Viability counts on the reconstituted vaccine suspensions were then carried out. Serial tenfold dilutions (1/10, 1/100, 1/1,000, etc.) were prepared in Sauton's medium with 0.025% triton WR 1339 added. The use of a fresh pipette for each dilution-step was found to be important, since the B.C.G. cells, which carry a low negative surface charge, are readily adsorbed on to the glass surface. Drops of 0.02 ml. each from a platinum-tipped pipette were placed on the surface of oleic acid-albumin agar with 10% human blood in petri dishes. About 10 drops were applied to each plate in a manner similar to that described by Miles et al. (1938) .
The colonies from each drop were counted under a stereo-binocular microscope after 21 days' incubation at 37°C. The most reproducible counts were obtained from the dilution giving between 10 and 50 colonies per 0.02 ml. drop. The viability counts of the reconstituted freeze-dried vaccines were obtained on multiplying the average number of colonies counted from each drop by the dilution used and by the number of drops per ml. (theoretically 50) delivered by the dropping-pipette. In practice, it was found that different pipettes delivered drops o^i slightly different sizes, so that it was necessary to calibrate each pipette (numbers of drops per ml.) and apply an appropriate correction factor.
Properties of the Freeze-dried B.C.G. Grown in Glycerol-free Medium (a) Survival on Freeze-drying There was a considerable increase in the proportion of organisms from the glycerol-free culture surviving the freeze-drying process when compared with cultures grown in Sauton's medium. Under similar conditions, on the average 57% of the former survived, whereas from the Sauton's medium cultures (with glycerol) survival was 29% (Table I ). Thus to achieve the same number of viable organisms in the vaccine after it has been freeze-dried it is necessary to fill into the ampoules only about a half of the number that would be needed had they been grown in Sauton's medium. Before freeze drying or after drying and subsequent reconstitution, the B.C.G. cells in suspension were found to be just as readily killpd by heating as were those grown in Sauton's medium. Ten separate batches of vaccine of the heat-stable type were subjected to the tests for absence of virulence (in guinea-pigs), for local lesion formation (Jensen test), and for skin-sensitizing potency (in guinea-pigs), in accordance with the British Therapeutic Substances Regulations . In these tests the batches of heat-stable vaccine were so prepared as to have viability counts falling between the same limits (not less than 4 x 106/ml. and not more than 9 x 106/ml.) as the routine batches of vaccine, prepared from Sauton's medium cultures, under test at the same time. The tests showed that the heatstable vaccines gave exactly the same results as the control vaccines prepared in Sauton's medium. It wa-s therefore concluded that batches of vaccine could safely be tested in human subjects. To make the most valid comparison possible, three pairs of vaccines (heat-stable and control) were compared on separate occasions. The pairs were deliberately (Griffiths and Gaisford, 1956 ). Those infants in whom a sufficient period had elapsed (batches 323 and 325 given in 1960) were tuberculintested (10 T.U. of O.T.) one year after vaccination.
The number of infants exam-ined and the results of tuberculin-testing are shown in Table V glycerol. This finding is in accordance with the hypothesis that some metabolic product of glycerol, at present unidentified but probably an aldehyde or pyruvate, has a toxic action on the B.C.G. cells in the dried state. Glycerol itself would not appear to be incriminated, since the addition of glycerol to the freezedrying menstruum for cells grown in the absence of glycerol had no adverse effect. It seems possible that the metabolic product of the glycerol contains a carbonyl group capable of reacting to form a toxic " browning reaction" compound in the manner described by Scott (1960) .
Laboratory tests and tests on experimental animals have shown that, apart from surviving better during the freeze-drying process and on storage in the dried state, the B.C.G. cells grown in the new glycerol-free medium have the same biological properties as those grown on Sauton's medium containing glycerol. After this finding it seemed justified to compare on babies the relative tuberculin-sensitizing powers of the heat-stable and control vaccines; the results have shown that the effects of the two types of vaccine are identical. Further, the two types of vaccine give the same incidence of local reactions at the vaccination site. We therefore conclude that the heat-stable vaccine would be as acceptable for vaccination as the more thermolabile vaccine it is meant to replace.
The increased resistance to heat of the new vaccine will have obvious advantages in the field. Normal unrefrigerated transportation will generally be permissible. and accidental short exposure to even relatively high temperatures should not prove disastrous to the efficacy of the vaccine. It is not suggested that the vaccine is so stable as to permit abuse of recommended storage conditions; it should, however, enable fully viable B.C.G. vaccine to reach persons living in remote districtm in tropical and subtropical countries, where they might otherwise be de-nied the protection afforded by B.C.G. vaccination. Summary A method is described for preparing freeze-dried B.C.G. vaccine with increased stability to heat.
The method involves growing the B.C.G. cells from which the vaccine is prepared in a glycerol-free medium.
The hypothesis is advanced that absence of some toxic product of glycerol metabolism permits this stability.
Apart from a greater stability to heat, the new vaccine has the same biological properties as a control vaccine of the same viability prepared in conventional culture media.
Batches of heat-stable and control vaccines of the same viability have the same allergenic properties when used to vaccinate babies and produce similar local reactions at the vaccination site.
The more heat-stable vaccine will have obvious advantages for distribution and use in tropical and subtropical countries.
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